Howard Rutman
![Howard Rutman Howard Rutman](https://www.als-drug-development.com/wp-content/uploads/sites/702/2024/01/Howard-Rutman-150x150.jpg)
Company: Xalud Therapeutics
Job title: Chief Medical Officer
Seminars:
Translating A Non-Viral Anti-Inflammatory Gene Therapy into ALS Mouse Models & Preparing for First In-Human Studies 1:10 pm
Developing a unique therapeutic approach of targeting IL-10 with a non-viral gene therapy Showcasing preclinical data of anti-inflammatory effect in TDP-43 mouse models Outlining future directions for translation into phase 1 clinical studyRead more
day: Day Two Track A PM